Companies / VRTX vs JNJ
VRTX vs JNJ: Vertex Pharmaceuticals and Johnson & Johnson
Vertex Pharmaceuticals (VRTX) reported $12.0B in revenue against a 32.9% net margin, while Johnson & Johnson (JNJ) reported $94.2B at a 28.5% net margin, most recently.
| Metric | VRTX | JNJ |
|---|---|---|
| Revenue | $12.0B | $94.2B |
| Net Income | $4.0B | $26.8B |
| Gross Margin | 86.2% | 67.9% |
| Operating Margin | 34.8% | — |
| EPS (Diluted) | $15.32 | $11.03 |
| Free Cash Flow | $3.2B | $19.7B |
| Total Debt | — | $49.9B |
| P/E Ratio | 29.6× | 18.8× |
| P/B Ratio | 6.2× | n/m |
| Stock Price | $542.69 | $272.48 |
Free: last 5 years
| Fiscal year | FY2008 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VRTX Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $7.6B | $8.9B | $9.9B | $11.0B | $12.0B |
| JNJ Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $82.6B | $78.7B | $85.2B | $88.8B | $94.2B |